Insider trades
Peter Heerma, Chief Officer of Travere Therapeutics TVTX, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 05/05.
Peter Heerma
Chief Commercial Officer
- Company
- Travere Therapeutics TVTX
- First filing
- 23/01/26
- Trades
- 37 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$1.1M
- Last trade
- 05/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/05 | 05/06 | 2,174 sh | $46.65 | $101,417.1 | −1.5% | |
| Open-market sale | 04/14 | 04/15 | 7,215 sh | $41.93 | $302,524.95 | −4.9% | |
| Open-market sale | 02/03 | 02/03 | 7,310 sh | $32.12 | $234,797.2 | −5.3% | |
| Open-market sale10b5-1 plan | 25/12/24 | 25/12/29 | 4,980 sh | $40.00 | $199,200 | −4.2% | |
| Open-market sale10b5-1 plan | 25/10/31 | 25/11/04 | 5,591 sh | $35.00 | $195,685 | −4.5% | |
| Open-market sale10b5-1 plan | 25/10/28 | 25/10/30 | 2,662 sh | $30.00 | $79,860 | −2.1% | |
| Open-market sale | 25/05/05 | 25/05/05 | 1,771 sh | $21.05 | $37,279.55 | −1.4% | |
TVTX | Open-market sale10b5-1 plan | 25/02/11–25/02/12 | 25/02/12 | 5,642 sh2 trades | $24.33avg. | $137,275.04 | −4.3% |
| Open-market sale | 25/02/03 | 25/02/04 | 5,166 sh | $20.12 | $103,939.92 | −4.0% | |
| Open-market sale | 25/01/22 | 25/01/23 | 1,584 sh | $18.94 | $30,000.96 | −1.5% | |
| Open-market sale | 24/09/09 | 24/09/09 | 2,191 sh | $11.52 | $25,240.32 | −2.0% | |
| Open-market sale | 24/02/01 | 24/02/02 | 4,195 sh | $8.53 | $35,783.35 | −4.0% | |
| Open-market sale | 24/01/23 | 24/01/25 | 1,559 sh | $9.07 | $14,140.13 | −1.9% | |
| Open-market sale | 23/10/03 | 23/10/04 | 3,091 sh | $8.25 | $25,500.75 | −3.7% | |
| Open-market sale | 23/02/01 | 23/02/02 | 1,779 sh | $21.75 | $38,693.25 | −2.1% | |
| Open-market sale | 23/01/24 | 23/01/26 | 1,550 sh | $21.90 | $33,945 | −2.4% |